The Cure Cancer Project: Prominent Supporters of the Cure Cancer Project

Prominent Supporters of the Cure Cancer Project

The Cure Cancer Project is being formed by a group of scientists, physicians, and individuals who are deeply committed to the cure of cancer and recognize the urgent need for therapies based on a new conceptual model of cancer.

The project is currently in the organizational stage. Scientists from many major research institutions have expressed an interest in being actively involved in the Cure Cancer Project and the development of the core technology.*

Editorial Proposing the Cure Cancer Project

An editorial proposing the Cure Cancer Project was generated and signed by many prominent cancer researchers and physicians.

Download the editorial [420KB PDF]

Signers of the Editorial

Dr. Emil Frei III

Physician-in-Chief Emeritus, Dana-Farber Cancer Institute
The Richard and Susan Smith Distinguished Professor of Medicine, Harvard Medical School
Lasker Award Recipient for developing cures for leukemia and lymphoma
Past President of the AACR

Arthur C. Upton, M.D.

Former, Director of the National Cancer Institute
Professor, Environmental and Occupational Sciences Institute
University of Medicine and Dentistry of New Jersey

Lawrence A. Loeb, M.D., Ph.D.

Professor of Pathology and Biochemistry
University of Washington School of Medicine
Past President of the AACR

Craig Webb, Ph.D.

Director, Program of Translational Medicine
Van Andel Research Institute

Harvey I. Pass, M.D.

Chief, Division of Thoracic Surgery and Thoracic Oncology
Department of Cardiothoracic Surgery
NYU School of Medicine and NCI Cancer Center

Bernie Crespi, Ph.D.

Professor of Evolutionary Biology
Department of Bioscience
Simon Fraser University

Michael Liebman, Ph.D.

Executive Director
Windber Research Institute

Richard I. Somiari, Ph.D.

President and Chief Science Officer
ITSI-Biosciences

Dr. Henry H. Q. Heng, Ph.D.

Associate Professor, Molecular Medicine and Genetics
Wayne State University School of Medicine
Karmanos Cancer Institute

Arnold Glazier, M.D.**

Founder and C.E.O.
Drug Innovation and Design, Inc.

* This does not imply that the listed institutions endorse or support the project.

**Author of editorial